- Therapeutic miR-506-3p Replacement in Pancreatic Carcinoma Leads to Multiple Effects including Autophagy, Apoptosis, Senescence, and Mitochondrial Alterations In Vitro and In Vivo
Hannes Borchardt et al, 2022, Biomedicines CrossRef - MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
Behnaz Lahooti et al, 2021, Frontiers in Oncology CrossRef - Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment
Atqiya Fariha et al, 2022, Heliyon CrossRef - A review on the role of cyclin dependent kinases in cancers
Soudeh Ghafouri-Fard et al, 2022, Cancer Cell International CrossRef - Development of a potency assay for CD34+ cell-based therapy
Anne Aries et al, 2023, Scientific Reports CrossRef - microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 2
Wenshan Chen et al, 2023, Journal of Chemotherapy CrossRef - Exosomal microRNA-506 inhibits biological activity of lung adenocarcinoma cells and increases sensitivity to cisplatin-based hyperthermia
Kunming Zhang et al, 2022, Cellular Signalling CrossRef - Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle Progression
Archana Shrestha et al, 2024, International Journal of Molecular Sciences CrossRef